The FGF/FGFR Signalling Pathway:
NCT03303885
·
clinicaltrials.gov ↗
COMPLETED
Status
421
Enrollment
OTHER
Sponsor class
Conditions
Liposarcoma
Sponsor
Centre Hospitalier Universitaire de Nice